iPMI Magazine Is Proudly Sponsored By:
For a healthier journey.
Healthcare International
iPMI Magazine

iPMI Magazine

International Private Medical Insurance Magazine (iPMIM) is the ultimate Health and Medical Insurance Digital Media serving expatriate, corporate, health and travel insurance markets. Due to the nomadic nature of the international healthcare industry iPMI Magazine is an internet based news service, for worldwide healthcare professionals, who need to understand the impacts of healthcare and insurance policy, regulatory, and legislative developments. Combined with in depth health insurance industry analysis, best-in-class health insurance industry data, and exclusive, C-Suite Executive health insurance interviews and round tables, iPMI Magazine bridges an information gap between healthcare payor, provider and patient. Written by the health and medical insurance industry, for the health and medical insurance industry, iPMIM is supported and designed by leading international medical insurance companies and service providers.

Website URL:

IMG Welcomes Dina Tarantola-Froner As Chief Underwriting Officer

International Medical Group® (IMG®) is excited to introduce Dina Tarantola-Froner as the company's new Chief Underwriting Officer. Dina joins the IMG team with more than 30 years of underwriting experience and extensive knowledge of the insurance industry.

Dina will be responsible for leading the global underwriting and products teams at IMG where she will ensure underwriting and product initiatives meet the needs of today's dynamic and competitive global marketplace. Additionally, Dina will work alongside the senior leadership team to strengthen the company's underwriting strategy and create business plans that further position IMG as the leader of travel and health safety solutions for people traveling and residing away from home.

"I want to make sure IMG is making sound underwriting decisions and that there are efficient processes in place to provide excellent service to all of our stakeholders in our various segments," Dina said. "I'm excited for the opportunity to apply my knowledge and experience to help drive strategic growth at IMG."

Prior to joining IMG, Dina held senior leadership roles at Liberty Mutual Insurance, Hartford Financial Services, and AIG—where she spent 25 years, ultimately serving as the National Underwriting Officer and overseeing all accident and health underwriting for the U.S. and Canada.

A lifelong New Yorker from Brooklyn, Dina is married with two children. She says she looks forward to making a global impact through her new role as Chief Underwriting Officer at IMG.

"We're excited to welcome Dina to IMG. Her extensive underwriting and leadership experience makes her a fantastic addition to the team," said IMG President and CEO, Steve Paraboschi. "I'm confident that Dina will be able to successfully assist IMG on our path to continued growth in the marketplace."

GBG Introduces New Brand and Website

Global Benefits Group (GBG), a specialty insurance organization administering international health, life, disability, and travel insurance today announced the launch of its new brand and newly designed website,

The redesigned site brings together their regions and divisions all under one holistic site.

The new website provides visitors and partners with a simpler way to learn about GBG’s capabilities on a cutting-edge platform. 

Chris DiSipio, Chief Executive Officer, Global Benefits Group, comments, "We are proud to introduce the new GBG brand as it aligns with our continued dedication to serve customers around the world."

GBG has nearly 40 years of experience providing support and guidance around the world.  The new brand demonstrates the passionate team of experts that handles the intricacies of international insurance so clients can live their life no matter where their lives take them…Go, we’ll be there!

Learn more by watching our latest corporate video, then come explore the new GBG at

ABOUT GBG: Global Benefits Group (GBG) is a global insurance group that administers and underwrites international health, life, disability, and travel insurance. With a client base that spans multinational corporations, expatriates, international students, high net-worth individuals, international schools, and non-profit organizations, GBG is committed to delivering outstanding customer service to the globally mobile population.

Global Benefits Group (GBG) is the marketing name for GBGI Limited and its subsidiary and affiliated companies. 

International Private Medical Insurance Magazine Provider Network Directory January 2022

Welcome to iPMI Magazine 2022.

The January 2022 edition of the International Private Medical Insurance Magazine Provider Network Directory, is out now, featuring over 80 pages of international private medical insurance and medical assistance company intelligence.

The iPMI Magazine network consists of a wide range of leading international medical payors and service providers, on call, 24/7 to assist you manage worldwide medical risks during a global pandemic.

The international medical insurance network covers all sectors of the global medical insurance business, and you can use the directory to source new partners and service providers. Simply use the the contact details within the network directory to connect with new partners and customers. 

The IPMI market use the iPMI Magazine Provider Network Directory to source the best information and data on international private medical insurance payors and providers. They may be searching for a new partner, looking for a contact number of a current provider, or researching the payor and provider market for future cross border network development.


Classifications include: IPMI, Assistance, Air Ambulance, Cost Containment And Claims Management, Funeral Directors, Ground Ambulance, Healthcare Insurance Management and Pharmacy Benefits Management.

Current Provider Network Members 

Click a company name below to visit their micro web site on iPMIM and learn more or download the brand new e-directory using the above link. To add your business to the e-directory and launch a micro website please write to David Bond, CIO, iPMIM on ipmi[at]










AXA Completes Sale Of AXA Bank Belgium

AXA has announced that it has completed the sale of its Belgian banking operations, AXA Bank Belgium, to Crelan Bank NV/SA (“Crelan”), for a total consideration* of Euro 691 million, comprised of (i) a net cash consideration of Euro 611 million** , and (ii) the transfer to AXA Belgium of 100% of Crelan Insurance*** (valued at Euro 80 million).

In addition, AXA and Crelan have entered into a long-term P&C and Protection insurance distribution partnership which will be effective on January 1, 2022, extending the existing partnership between AXA Bank Belgium and AXA Belgium to the entire Crelan network.

Thomas Buberl, CEO, AXA comments, "The completion of this transaction marks another step in AXA’s simplification journey. We are pleased to maintain strong links with AXA Bank Belgium through this long-term partnership and to further extend it to Crelan’s network. I would like to thank the AXA Bank Belgium teams for their continuous contribution and engagement over the years and wish them all the success for the future with Crelan, leveraging on their combined scale and product offering."
The parties have amended their original agreement whereby AXA has today subscribed Additional Tier 1 debt**** issued by Crelan for an issue price of Euro 245 million instead of acquiring a minority equity stake of 9.9% in Crelan for Euro 90 million, as communicated at the time of the signing of the transaction. As per the terms of the initial agreement, Crelan has also purchased for Euro 90 million the contingent convertible bonds previously issued by AXA Bank Belgium to AXA Group. The completion of the transaction is expected to result in a positive impact of 4 points on AXA Group’s Solvency II ratio in 4Q21.

* In cash terms, AXA S.A. will receive Euro 691 million for the sale of AXA Bank Belgium and AXA Belgium will pay Crelan Euro 80 million for the purchase of Crelan Insurance.

** Including a price adjustment reflecting customary closing conditions.

*** The insurance company of Crelan, providing protection insurance linked to loans originated by Crelan.

**** Perpetual debt callable in 2027, subscribed by both AXA S.A. and AXA Belgium.

iPMI Magazine Speaks With Angela Smith, Head Of Proposition Development, Charles Taylor Assistance

Why is innovation so important to the health of the international assistance sector? As the Covid-19 pandemic shines a spotlight on global medical assistance, we ask Angela Smith, head of proposition development for Charles Taylor Assistance, to answer some key questions about the role of innovation in the sector

What’s driving innovation in global medical assistance?

The Covid-19 pandemic has accelerated demand from travellers for easy access to information and advice about real-time health and security risks abroad; covering everything from Covid-related travel restrictions to terrorist attacks.

Customers overseas want to know that a skilled assistance specialist will be available when they need them, that relevant information will be obtained quickly and efficiently and that queries about policies and claims validations will be settled speedily. In this context, they want to know that digitisation will ease their pre-and post-claims journeys and accelerate settlements where appropriate.

All this is putting the onus on assistance providers to create more bespoke solutions for insurer clients and their customers than ever.  In today’s climate, providers are expected to work with clients not just to establish their bespoke needs but also to offer the flexibility that enables them to choose the level at which they manage new products themselves, such as claims data dashboards and automated alerts.

In its Travel Megatrends 2025 report, the travel news site Skift reported that brands that embrace agility and flexibility will be equipped for the future of travel. And this couldn’t be more accurate.

What role does digitisation play?  

According to McKinsey’s Digital Patient Survey, more than 75% of all patients expect to use digital services in the future. And digitisation is already transforming both the medical claims journey and the travel risk mitigation landscape.

Seamless and fluid assistance is being driven by tools such as digital doctor, which integrates video doctor and advanced diagnostic services into the medical assistance process. Meanwhile, wider ways of enabling customers abroad to reach out for help and to improve information and assistance delivery are also being explored by the assistance sector, for instance via telemedicine and AI.

At the same time, reliance on mobile technology has driven services such as digital claims, single-source medical and security assistance, risk management alerts and automated medical screening. Other automated processes, such as bespoke telephony technology,  multi-currency payment technology, digital document signing and workflow management aids are also integral to the global assistance sector. And automation is easing processes with assistance suppliers and customers alike.  

But this provision needs to be constantly developed to drive further efficiencies in claims handling, supplier management, global network integration, cost containment, information gathering and more.

Why does innovation need to be a balancing act?

Recent digital developments here at Charles Taylor include Venture: a digital health risk assessment tool that helps corporates manage duty of care obligations for back-to-work and back-to-travel scenarios during the pandemic. Importantly, clients can choose the aspects of this process that they want to manage.

We’re also using digitisation to contain costs and create efficiencies via Discovery, our new court-compliant social media and open-source digital investigation tool for the fraud investigation arena. This uses algorithms to search over 220 open source and social media sites for impactful intelligence about claims and sets off referral alerts to professional investigators.

We recognise that technology is essential to capture important data and ease processes, but it will always need to be complemented by in-house human expertise. Niche skills, supported by innovative training are essential to ensure that assistance cases are managed effectively, interventions are made at the right time and customers’ individual needs are met, especially when they feel vulnerable. After all, every customer is different.

Skills management and maintenance, together with efficient knowledge transfer are critical in this respect and the frequency of training is as important as the methods.

How can we future-proof the assistance sector?

Today, looking beyond Covid, the assistance sector needs to prepare not just for current risks, such as pandemics and terrorism, but also for the lesser known impact of issues such as climate change. We need to ask ourselves, for instance, if climate change will drive travellers away from traditional tourist destinations, disrupting not just where, but when they go abroad and how they get there? Or if increasingly unpredictable weather patterns will create more emergencies overseas - and if we need to adapt assistance provision to mitigate this?

Cutting-edge technology, flexibility, human expertise and collaboration will, together, be key to effective innovation in this respect.  So too will investment in research and development.  And we need to bear this in mind as we forge ahead in today’s ever-changing travel landscape.

Global Ventures Attracts New Investment For Its Second Fund From Bupa Arabia

Global Ventures, the UAE-based international venture capital firm investing in emerging market founders, technology and ideas scaling across MEA and the world, is excited to announce new investment from Bupa Arabia, the leading health insurance company in the region.

Bupa Arabia’s participation in Global Ventures Fund II as strategic partner will foster the healthcare ecosystem in the region and particularly in Saudi Arabia. The investment by Bupa Arabia is part of the company’s strategy to participate and invest in disruptive healthcare and insurance technologies, amongst other targeted growth sectors. The company had recently announced receiving regulatory approvals to establish Bupa Arabia Ventures; which will expand its investment portfolio in technology companies.

Global Ventures’ second fund is focused on technology companies addressing critical needs and demands in recently accelerated industries. It continues to be a leading provider of capital and value creation for start-ups in the region, with a timely and increasing focus on Digital Health.

To date, Global Ventures has invested in 44 companies, across 10 markets, using capital from its two funds.

Noor Sweid, Founder & General Partner of Global Ventures, commented, “Global Ventures’ Fund I has been a great success, and we are delighted to welcome Bupa Arabia to Fund II, and also join us in a deeper, strategic partnership. Bupa Arabia shares our outlook and ambition on the Digital Health sector, and its potential for technology and innovation to deliver long-term economic benefits particularly in emerging markets.”

Nader Ashoor, Chief Financial Officer of Bupa Arabia said, “We are excited about Global Ventures’ Fund II prospects. We are quite pleased with Global Ventures governance, capabilities, investment approach and track record, and look forward to activate our strategic partnership in the new future.”      

Global Ventures is a UAE-based international venture capital firm, investing in founders and ideas scaling across emerging markets. Global Ventures backs global-minded founders that are leading growth-stage companies and using technology to transform emerging markets.

Portfolio companies include Altibbi, Arrow Labs, Buseet, Cartona, Elmenus, Floranow, Helium Health, Holiday Me, Mamo, Much:on, Ogram, Paymob, Proximie, Pyypl, Spider Silk, Tabby, Tarabut Gateway, Team Apt, Tribal, Yodawy and Zension.

Noor Sweid and Basil Moftah are the General Partners of Global Ventures.

Bupa Arabia is a leading healthcare insurance company in Saudi Arabia with a purpose to help people live, longer, healthier, happier lives and make a better world. In doing so, it has been leading the industry’s service innovation such as Tebtom program - that offers a bouquet of healthcare services such as chronic management, medication refill and delivery, maternity and childcare and international second medical opinion – and Rahatkom program – that offers its insured members red carpet services at the providers to guide and facilitate their services at the points of care.

Its revamped smart phones app has exceeded 1.5 million downloads offering members with personalized and innovative services with instant medical appointments being the latest introduction.

Bupa Arabia has recently received the regulatory approval to establish Bupa Arabia Ventures, the first healthcare corporate venture capital firm focused on investing in disruptive technologies in the region and beyond.



iPMI Magazine Speaks With Damian Lenihan, Executive Director, Distribution and Operations, Europe, Aetna International

In this exclusive iPMI Magazine interview, Christopher Knight, CEO, iPMI Magazine, met with Damian Lenihan, Executive Director, Distribution and Operations, Europe at Aetna International. They discussed in detail the iPMI market during Covid-19, plus recent award wins for Aetna International. 

Please introduce yourself and background in the international private medical insurance market:

I’m Damian Lenihan, I head Operations and Distribution for Aetna International in Europe, which I joined in 2015. Prior to Aetna, I spent over 20 years at Bupa where I was, latterly, Sales Director at Bupa Care Homes and a board member for Bupa Care Services. I’ve also volunteered as vice chair of governors at a local school for five years. 

Aetna International recently won ‘Best Individual International Healthcare Provider’ at the UK Health & Protection Awards and were also highly commended by the judges for ‘Best Group International Private Medical Insurance Provider’. What does this mean to Aetna International and the iPMI market?

We’re always happy to win prestigious awards because every year throws up unique challenges for us and our industry. This year we were thrilled to collect Best Individual International Healthcare Provider for the first time, especially as this is a segment that we’ve invested in for several years to provide excellent products and services to a growing number of members.

Best Group International PMI Provider is an award we won for eight consecutive years, so we’re pleased to still be highly commended this time around and we’re confident our offering remains strong. 

Currently, what percentage of business is group iPMI, and what % of business is individual?

Our business is largely corporate, but we’re also focused on Individual, which we’ve expanded and grown sustainably over the last five years. We are looking to have a balanced business.

What are the advantages of working with an award winning iPMI provider?

There are many advantages of working with a multi-award winning iPMI provider. However, it’s not one award nor a single awards season that makes a difference. At Aetna International we’ve developed our products, our services, our knowledge and expertise and our global medical networks over the past 55 years. We’re always striving to improve in everything we do and we’re constantly looking for better ways to look after our members. We listen to our broker partner, clients and members and focus on making it as easy as possible for our clients to take care of their employees and on empowering our members to look after themselves. We call this a well-care model and our members – whom we treat as individuals – have access to an excellent set of resources, from telemedicine through to tools to support their physical, mental and emotional well-being.

In the past 18 months, as a result of the COVID-19 pandemic, we’ve significantly strengthened our mental health and well-being services and invested in all the tools our members expect and need.

In a nutshell, we're a people business at heart at Aetna International. It’s the passion, energy, creativity and determination of our teams to serve our members as individuals around the clock, every day of the year, that truly sets us apart.

Since COVID-19, how has the international private medical insurance market changed?

In the past 18 months we’ve all seen how mental and emotional health has become much more important for many people around the world. Our research has revealed that employees now have greater expectations than they did pre-pandemic – they want comprehensive mental health and well-being services as standard.

As a result, employers need to carefully choose the best plans for their valued workforce – plans that cover everything from health support, advice and guidance through to telemedicine and digital tools. We understand that employers also need to control their costs and are less likely to switch insurers at the moment. They want to work with a health insurer they know and can deliver the right level of support for their employees.

What are the biggest current risks faced by the international private medical insurance market?

It’s well known that many people avoided seeking health care when they needed it during the height of the pandemic. In some cases, people who actively needed treatment couldn’t access it because hospitals were full dealing with COVID-19 patients. Those with mild symptoms or well-controlled long-term conditions also hesitated to consult with their health care provider. As people avoided or couldn’t access their health care settings, this may result in more disease complications in the future.

Can you walk us through how Aetna International iPMI plans to protect expatriates against COVID-19?

Naturally, we want to help protect all of our members from COVID-19. We offer outpatient tests and diagnostic procedures for communicable diseases when members don’t have signs or symptoms, and they aren’t received in relation to a diagnosed medical condition. The benefit extends to outpatient antibody tests. This is open for anyone who started or renewed our Pioneer 2500-5000+ plans on or after 1 January 2021 and it’s an optional benefit on all our Summit plans.

For new Individual members who join us on a Moratorium or Full Medical Underwriting basis, we provide cover for COVID-19 diagnostic testing, treatment and evacuation, provided they have no pre-existing symptoms or diagnosis of COVID-19.

And, of course, all eligible members have free access to our telemedicine service, vHealth. It’s a really convenient way of talking to a doctor via phone or video link about any aspect of their health or well-being, without the worry of travelling to a medical facility and possibly catching infections.

Due to COVID-19 expats and local workers of global companies and HNW individuals may no longer have the option of flying home or to another country for medical treatment so may have to rely on local healthcare. Is PMI and iPMI merging?

I suspect we’ve seen an increase in individuals and high-net-worth businesses switch from local PMI to IPMI to give them greater flexibility and also gain the additional benefits of coverage for services such as GP visits and maternity care. With IPMI members also have the flexibility to travel to receive their treatment – something that local PMI doesn’t provide.

Many standard medical procedures have been cancelled due to the pandemic. What will the cost of deferred healthcare be?

This is a key question and for the moment it remains to be seen. We certainly feel that with the pandemic people will have delayed or had difficulty seeing a doctor or consultant and therefore we may see people requiring more extensive treatment because conditions might be diagnosed later. However, we can’t yet say how much that might occur. One of the things we implemented for our members was access to a 24-hour video GP service in the hope that people could still get a diagnosis via the service. We saw a substantial uptake of this during Covid.

Last, but not least, if you could live anywhere in the world, on land, or at sea, where would it be?

It’s difficult to say as there is so much of the world I want to see. It would definitely be somewhere warm and at the moment my favourite country is Italy, so perhaps the Amalfi Coast.


Follow WHO Advice: Rescind Travel Bans

The International Air Transport Association (IATA) called for governments to follow World Health Organization (WHO) advice and immediately rescind travel bans that were introduced in response to the Omicron variant of the coronavirus.

Public health organizations, including the WHO, have advised against travel curbs to contain the spread of Omicron. WHO advice for international traffic in relation to the SARS-CoV-2 Omicron variant states that:

“Blanket travel bans will not prevent the international spread, and they place a heavy burden on lives and livelihoods. In addition, they can adversely impact global health efforts during a pandemic by disincentivizing countries to report and share epidemiological and sequencing data. All countries should ensure that the measures are regularly reviewed and updated when new evidence becomes available on the epidemiological and clinical characteristics of Omicron or any other variants of concern.”

Time-Limited Science-Bases Measures

The same WHO advice also notes that states implementing measures such as screening or quarantine “need to be defined following a thorough risk assessment process informed by the local epidemiology in departure and destination countries and by the health system and public health capacities in the countries of departure, transit and arrival. All measures should be commensurate with the risk, time-limited and applied with respect to travelers’ dignity, human rights and fundamental freedoms, as outlined in the International Health Regulations.” 

“After nearly two years with COVID-19 we know a lot about the virus and the inability of travel restrictions to control its spread. But the discovery of the Omicron variant induced instant amnesia on governments which implemented knee-jerk restrictions in complete contravention of advice from the WHO—the global expert,” said Willie Walsh, IATA’s Director General.

Cleaning Up the Mess

IATA urges governments to reconsider all Omicron measures. “The goal is to move away from the uncoordinated, evidence absent, risk-unassessed mess that travelers face. As governments agreed at ICAO and in line with the WHO advice, all measures should be time-bound and regularly reviewed. It is unacceptable that rushed decisions have created fear and uncertainty among travelers just as many are about to embark on year-end visits to family or hard-earned vacations,” said Walsh. 

The industry demand asks governments to implement commitments that they have made through ICAO:

“We also commit to a multilayer risk management strategy for international civil aviation, which is adaptable, proportionate, non-discriminatory and guided by scientific evidence in close cooperation and coordination with the public health sector, with agreed practices harmonized to the greatest extent possible, for air travel purposes, using commonly accepted epidemiological criteria, testing requirements and vaccination, and underpinned by regular review, monitoring and timely information-sharing among States,” (ICAO HLCC Ministerial Declaration).

“Despite this clear commitment, very few governments have addressed early over-reactions to Omicron. With the European CDC already signaling that a de-escalation of measures will likely be needed in the coming weeks, governments must urgently put actions behind the commitments that they made at ICAO,” said Walsh.

European Centre for Disease Control and Prevention (ECDC) in the latest update to its Threat Assessment Brief  on the implications of Omicron in Europe notes that “given the increasing number of cases and clusters in the EU/EEA without a travel history or contact with travel-related cases, it is likely that within the coming weeks the effectiveness of travel-related measures will significantly decrease, and countries should prepare for a rapid and measured de-escalation of such measures.”

“Once a measure is put in place, it is very challenging to get governments to consider reviewing it, let alone removing it, even when there is plenty of evidence pointing in that direction.  That is why is it essential that governments commit to a review period when any new measure is introduced. If there is an over-reaction—as we believe is the case with Omicron—we must have a way to limit the damage and get back on the right track. And even in more normal circumstances, we must recognize that our understanding of the disease can grow exponentially even in a short period of time. Whatever measures are in place need to be constantly justified against the latest and most accurate scientific knowledge,” said Walsh.

View the COVID-19 October 2021 traffic data presentation (pdf)

Metlife Sees 250% Rise In Long-COVID Claims

MetLife UK has seen a 250% increase in Long-COVID claims in Q3, according to internal data findings.

The rise in claims comes as an estimated 1.2 million people in the UK have reported suffering with Long-COVID in the past four weeks. This is up from 1.1 million in October – a jump of nearly 10%.1  MetLife’s own claims data reveals that Long-COVID accounts for 10% of new Group Income Protection claims in the last three months – up 250% from the previous quarter2.

Those suffering from Long-COVID may experience symptoms such as fatigue, shortness of breath, loss of smell, chest pain and ‘brain fog’. Data also shows that while young people are less at risk of catching COVID-19, they are most likely to suffer from long-COVID. Data from the Office for National Statistics found that the prevalence of self-reported long-COVID was ‘notably higher’ among people aged 12 to 16 years or 17 to 24 years compared with the previous month. The figure for 17 to 24-year-olds was 2.4% (142,000), up from 1.9% (112,000).3

New figures from the NHS shows that only 5,000 people a month are being referred to specialist long-Covid clinics, with wait times reaching 15 weeks for first appointments. To help, MetLife, through its provision on Group Income Protection policies in partnership with HCB Group. Through this service, policyholders can get treatment within just a few days.

To further support those with Long-COVID, MetLife has also launched a Long-COVID pathway to help employees manage their symptoms and begin the process of returning to work after a period of the illness.

MetLife’s clinical pathway aims to minimise employee absence duration and prevent absence becoming long term. The pathway helps employers and employees understand the options available to them and provide tailored return to work support alongside:

  • Early Intervention case managers
  • Access to necessary treatment
  • Employee Assistance Programme (EAP) and wellbeing resources
  • Employee awareness modules
  • Training for employees and managers

MetLife UK paid almost £50 million in claims across its three core divisions in Q3, including Individual Protection, Group Protection and Employee Benefits Group Life. MetLife paid £38.75 million via the Employee Benefits Group Life division, £3.4 million via the Individual Protection division and a further £4.9m in Group Protection claims.

Stuart Lewis, Head of Claims at MetLife, comments, “From symptoms through to treatment so much remains unknown about Long-COVID, meaning that it’s no surprise that cases and claims are rising rapidly. At MetLife we’ve seen a clear uptick in the number of claims from our customers and have worked hard to provide the financial support they need as quickly as possible.

“In order to support our customers too we have recently launched our Long-COVID clinical pathway to help employees manage their symptoms and work towards returning to work as soon as they feel able to. Long-COVID symptoms can leave employees unable to concentrate or work altogether. Employers should reflect on the current employee benefits packages to see what support their provider can offer for Long-COVID. Already 1.2 million Brits are reported to be suffering from Long-COVID symptoms, and with the huge demand seeing waiting times of more than 15 weeks. For small businesses who can’t afford to lose key members of staff, ensuring that the return-to-work process is made as smooth as possible following time off with Long-COVID is paramount.”

Willis Towers Watson Makes Strategic Appointment In Australasia’s Construction And Natural Resources Team

Willis Towers Watson has announced the appointment of Kishan Dasan as Director of Strategic Growth – Construction and Natural Resources Australasia.

He will be based in Melbourne and take up his new role with the company on 13 December 2021.

Kishan joins Willis Towers Watson (WTW) from AIG where he was Head of Construction Asia Pacific. This is a new role created to meet a key need within the construction and natural resources sectors. Kishan will work across both of WTW’s teams to provide a seamless service to clients throughout the life of their projects.

Iain Drennan, Head of Construction Australasia, WTW said: “Kishan has been at the forefront of some of the region’s largest construction and energy projects, having spent over 13 years with AIG, including writing the largest construction and mining project seen to date in Australia. With long experience in underwriting and being a qualified engineer, Kishan brings unparalleled expertise and insights that will uniquely benefit WTW clients across the lifecycle of their projects, taking their risk mitigation and management strategies to a new level.”

Matt Frost, Head of Natural Resources for Australasia said: “Kishan had a large energy and power portfolio within his remit at AIG. His knowledge of those clients and their pinch points, will enable us to better tailor our solutions to meet those particular needs.”

Kishan’s appointment is the first of its kind for WTW Australia. “It is effectively a joint venture between our construction and natural resources teams. Kishan’s unique skillset and experience will deliver benefits for clients right across this growing part of our business and help us identify further strategic opportunities. This appointment is the embodiment of our ‘One WTW’ approach worldwide as we strive to deliver best-in-class integrated solutions,” added Ian.

Commenting on his new role, Kishan said: “I am very excited to join WTW and look forward to working with clients on seamless tailored solutions across the lifecycle of their projects.”

Subscribe to this RSS feed